ROLE OF MEAN APPARENT DIFFUSION COEFFICIENT (ADC) VALUE IN DIFFERENTIATION OF HIGH- AND LOW-GRADE GLIOMAS ON CONTRAST-ENHANCED MRI
Article Sidebar
Main Article Content
Abstract
Objectives: The purpose of our study was to determine the role of mean apparent diffusion coefficient (ADC) values in differentiating low-grade from high-grade gliomas, keeping conventional MRI sequences as a gold standard
Methods: This study was done in Lady Reading Hospital from September 2022 to December 2023. The prospective cross-sectional descriptive study included patients from the Out-Patient Department and Neurosurgery wards. Patients underwent MRI on a 1.5 Tesla machine, acquiring T2WI, T1WI, FLAIR, DWI, and gadolinium-enhanced T1WI sequences. PACS software identified areas with restricted diffusion and low ADC values. ROI measurements were made to determine ADC values. Image artifacts and contrast enhancement patterns were noted. Data on patient demographics, lesion location, MRI features, and ADC values were analyzed with SPSS-23.
Results: A total of 104 patients were included, with ages ranging from 3–87 years (Mean 41 years, ± 19.5), with 62 having low-grade gliomas and 42 high-grade gliomas. The mean ADC values were 1334.37 ± 300.85 mm2/s for low-grade and 842.88 ± 232.013 mm2/s for high-grade gliomas. The sensitivity and specificity of low ADC for high-grade glioma are 83.33 % and 77.42%, respectively. The optimal ADC cut of 1086.58 mm2/s significantly correlated with glioma grading (p < 0.001). Multiple linear regression revealed a significant relationship (p < 0.001) between mean ADC and tumor enhancement. Notable associations between ADC cut-off and enhancement were identified (p = 0.001).
Conclusion: The ADC values serve as a non-invasive and reliable radiological marker in distinguishing low-grade and high-grade gliomas. They improve the diagnostic accuracy of conventional MRI and aid in preoperative decision-making, reducing the need for invasive tissue biopsy.
Keywords:
ADC, gliomas, MRI, peritumoral edema, tumor enhancement.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
